BofA Securities has initiated coverage of Supernus Pharmaceuticals (ticker: SUPN) with a “buy” rating, citing the market’s undervaluation of the company’s portfolio of central nervous system...
During the BofA Securities 2025 Global Real Estate Conference on September 10, 2025, Kimco Realty Corporation (NYSE: KIM) shared insights into its growth strategy and market...
